|
|
According to the FDA, adverse drug events harmed or killed approximately 1,200,000 people in the United States in the year 2015.
Fatal fungal infections may be able to resist newer antifungal drugs. Globally, fungal infections are often fatal due to the lack of access to multiple antifungals, which may be required to be utilized in combination. Single antifungals may not be enough to stop a fungal infection from causing the death of a patient.
The newest statin drug, rosuvastatin, has been called a superstatin because it appears to reduce LDL cholesterol to a greater degree than the other approved statin drugs.
People with high total cholesterol have about two times the risk for heart disease as people with ideal levels.
About 100 new prescription or over-the-counter drugs come into the U.S. market every year.